Telo Genomics Corp.
TELO.V
TSX
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -377.70K | -393.30K | -510.80K | -588.90K | -438.80K |
| Total Depreciation and Amortization | 14.30K | 2.00K | 2.10K | 2.00K | 2.30K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | 83.10K | 153.20K | -- |
| Change in Net Operating Assets | 210.30K | 173.00K | 93.50K | -260.30K | 146.50K |
| Cash from Operations | -153.10K | -218.30K | -332.00K | -694.00K | -289.90K |
| Capital Expenditure | -12.00K | -1.50K | 0.00 | -2.30K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -147.90K | -- | -- | -- | -- |
| Cash from Investing | -159.90K | -1.50K | 0.00 | -2.30K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 2.55M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | -500.00 | -220.00K |
| Cash from Financing | -- | -- | 0.00 | -300.00 | 1.66M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -313.00K | -219.80K | -332.00K | -696.60K | 1.37M |